Company
Korea (the Republic of)Tae Min Kim, M.D., Ph.D., Seoul, Korea (the Republic of) – FDA Inspections
Inspection records and compliance data for Tae Min Kim, M.D., Ph.D. in Seoul. 2 FDA inspections on record, 1 Form 483, last inspected August 29, 2025.
Company Profile
This profile covers Tae Min Kim, M.D., Ph.D. based in Seoul, Korea (the Republic of).
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected December 15, 2023. Last inspected August 29, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 29, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1283432 |
| December 15, 2023 | VAI | Human Drugs · Bioresearch Monitoring | 1226038 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Tae Min Kim, M.D., Ph.D.
FEI Number
3028696324
Address
101 Daehok-Ro, Jongno-gu, Seoul National University Cancer Hospital, Seoul, Korea (the Republic of)
Country
Korea (the Republic of)
ID: 65edf818-9c47-4104-9173-571185503eff